Holen Sie sich die Stockscreener-App
23.78
0.50%
-0.1596
Finanzdaten der Centessa Pharmaceuticals Plc Adr-Aktie (CNTA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
15.00 | - | - | - |
| Operating Expenses |
19.39%
54.65
|
45.78 | - | - | - |
| Benefits Costs and Expenses |
24.73%
49.56
|
39.74 | - | - | - |
| Costs And Expenses |
24.73%
49.56
|
39.74 | - | - | - |
| Operating Income/Loss |
77.58%
-54.65
|
-30.78 | -74.58 | -46.41 | -43.98 |
| Income/Loss From Continuing Operations Before Tax |
100.36%
-49.56
|
-24.74 | -110.28 | -41.96 | -43.11 |
| Income Tax Expense/Benefit, Deferred |
3.12%
1.026
|
0.995 | 0.398 | 1.254 | 0.567 |
| Income Tax Expense/Benefit |
44.31%
0.778
|
1.397 | 1.05 | 0.608 | 0.705 |
| Income/Loss From Continuing Operations After Tax |
92.63%
-50.34
|
-26.14 | -111.33 | -42.57 | -43.82 |
Net Income/Loss
|
92.63%
-50.34
|
-26.14 | -111.33 | -42.57 | -43.82 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.48%
133.68
|
133.03 | 5.9017 | 116.25 | 109.49 |
| Diluted Average Shares |
0.48%
133.68
|
133.03 | 5.9017 | 116.25 | 109.49 |
| Basic Earnings Per Share |
90.00%
-0.38
|
-0.20 | -0.91 | -0.37 | -0.40 |
| Diluted Earnings Per Share |
90.00%
-0.38
|
-0.20 | -0.91 | -0.37 | -0.40 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.85%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):